To provide a novel diagnostic compound of diseases associated with vascular cell adhesion molecule-1 (VCAM) expression, to provide a preparation method of the same, and to provide a use of the same in medical imaging.
There is provided a Signal-Link-Peptide that is a peptide comprising VCAM-targeting peptide, the VCAM-targeting peptide being: a compound selected from the group consisting of following peptides a)X1-X2-X3-X4-X5-X6-X7-X8-X9, preferably the peptide NNSKSHT, or b)X10-X11-X12-X13-X14-X15-X16-X17-X18, preferably the peptide CMKTDTRLC, and functional equivalents of the peptides; and a pharmaceutically acceptable salt of the compound a) or b). Furthermore, in the compound, Signal is a chelate that may or may not be coupled to a paramagnetic metal, radionuclide, and the radionuclide for PET imaging is Ga68.
OLIVIER ROUSSEAUX
ROBERT MULLER
CARMEN BURTEA
JP2007521254A | 2007-08-02 | |||
JPH10508315A | 1998-08-18 |
WO2006037882A1 | 2006-04-13 | |||
WO2003091391A2 | 2003-11-06 |
Masao Haruna
Hirotaka Yamaguchi
Toshi Gobe
Ryuichi Inoue
Toshimitsu Sato
Koichi Niimi
Tomohiko Kobayashi
Shinichi Watanabe
Masato Ozeki
Kazuya Kawamoto